ASCO24

ASCO24: BMS Eyes First-Line Treatment in Liver Cancer for Opdivo-Yervoy Combo

admin June 5, 2024 0

Pictured: BMS sign on a building in San Diego, California/iStock, JHVEPhoto Bristol Myers Squibbs’ combination approach could become a first-line option...

ASCO24: BMS Eyes First-Line Treatment in Liver Cancer for Opdivo-Yervoy Combo

Metastatic Liver Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND

National Kidney Foundation and Healthy.io Partner to Offer Free Kidney Health Testing on Capitol Hill

Global Liver Institute and King’s College Hospital NHS Foundation Trust Launch First UK-Based Advanced Advocacy Academy to Strengthen Liver Health Education and Awareness

Strive, MA Insurer Zing Expand Partnership Around Kidney Care

Halton Healthcare detailing ‘game-changing’ kidney cancer operation

ASCO24: BMS Eyes First-Line Treatment in Liver Cancer for Opdivo-Yervoy Combo

You may have missed

Metastatic Liver Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND

National Kidney Foundation and Healthy.io Partner to Offer Free Kidney Health Testing on Capitol Hill

Global Liver Institute and King’s College Hospital NHS Foundation Trust Launch First UK-Based Advanced Advocacy Academy to Strengthen Liver Health Education and Awareness

Strive, MA Insurer Zing Expand Partnership Around Kidney Care

Halton Healthcare detailing ‘game-changing’ kidney cancer operation